Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy, J Hematol Oncol, vol.6, p.49, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00845842
Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib, Onco Targets Ther, vol.7, pp.2249-2255, 2014. ,
Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells, Oncol Lett, vol.9, pp.1287-1292, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02378497
Endothelial side population cells contribute to tumor angiogenesis and antiangiogenic drug resistance, Cancer Res, vol.76, pp.3200-3210, 2016. ,
Tumor angiogenesis: Molecular pathways and therapeutic targets, Nat Med, vol.17, pp.1359-1370, 2011. ,
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship, Clin Cancer Res, vol.9, pp.327-337, 2003. ,
Antiangiogenic therapy in oncology: Current status and future directions, Lancet, vol.388, pp.518-529, 2016. ,
Drug resistance in cancer: An overview, Cancers (Basel), vol.6, pp.1769-1792, 2014. ,
Role of the tumor stroma in resistance to anti-angiogenic therapy, Drug Resist Updat, vol.25, pp.26-37, 2016. ,
Resistance to anti-angiogenic therapy: A clinical and scientific current issue, Med Sci, vol.32, pp.370-377, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02327134
Targeting cancer stem cells to overcome chemoresistance, Int J Mol Sci, vol.19, p.4036, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02124684
The potential role of lysosomes in tissue distribution of weak bases, Biopharm Drug Dispos, vol.9, pp.513-526, 1988. ,
Intracellular drug sequestration events associated with the emergence of multidrug resistance: A mechanistic review, Front Biosci, vol.10, pp.1499-1509, 2005. ,
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells), Drug Metab Dispos, vol.41, pp.897-905, 2013. ,
Lysosomal sequestration of sunitinib: A novel mechanism of drug resistance, Clin Cancer Res, vol.17, pp.7337-7346, 2011. ,
P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration, J Biol Chem, vol.288, pp.31761-31771, 2013. ,
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance, Oncotarget, vol.6, pp.1143-1156, 2015. ,
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature, Leukemia, vol.22, pp.844-853, 2008. ,
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells, Br J Cancer, vol.109, pp.1040-1050, 2013. ,
Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells, J Pharmacol Sci, vol.121, pp.67-73, 2013. ,
Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries, Chem Biol Interact, vol.217, pp.28-40, 2014. ,
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux, Autophagy, vol.11, pp.1891-1904, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02108861
Self-eating and self-killing: Crosstalk between autophagy and apoptosis, Nat Rev Mol Cell Biol, vol.8, pp.741-752, 2007. ,
Insights into autophagosome biogenesis from in vitro reconstitutions, J Struct Biol, vol.196, pp.29-36, 2016. ,
Emerging mechanisms in initiating and terminating autophagy, Trends Biochem Sci, vol.42, pp.28-41, 2017. ,
Autophagy modulation as a potential therapeutic target for diverse diseases, Nat Rev Drug Discov, vol.11, pp.709-730, 2012. ,
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: From pathophysiology to treatment, J Hematol Oncol, vol.10, p.67, 2017. ,
Mechanisms and functions of lysosome positioning, J Cell Sci, vol.129, pp.4329-4339, 2016. ,
Monitoring and measuring autophagy, Int J Mol Sci, vol.18, p.1865, 2017. ,
Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy, Mol Aspects Med, vol.27, pp.495-502, 2006. ,
Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase, Curr Med Chem, vol.6, pp.1197-1212, 1999. ,
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion, Autophagy, vol.14, pp.1435-1455, 2018. ,
Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH, J Cell Biol, vol.108, pp.855-864, 1989. ,
Molecular definitions of autophagy and related processes, EMBO J, vol.36, pp.1811-1836, 2017. ,
Autophagy: Shaping the tumor microenvironment and therapeutic response, Trends Mol Med, vol.19, pp.428-446, 2013. ,
Tumor vessel normalization by chloroquine independent of autophagy, Cancer Cell, vol.26, pp.190-206, 2014. ,
Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma, Cancer Res, vol.70, pp.1053-1062, 2010. ,
Cardiovascular toxic effects of targeted cancer therapies, N Engl J Med, vol.375, pp.1457-1467, 2016. ,
Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management, Bull Cancer, vol.103, pp.259-272, 2016. ,
, This work is licensed under a Creative Commons Attribution-NonCommercial